Skip to Content

New Drug Approvals Archive - February 2016

See also: New Indications and Dosage Forms for February 2016

February 2016

Sernivo (betamethasone dipropionate) Topical Spray

Date of Approval: February 5, 2016
Company: Promius Pharma, LLC
Treatment for: Plaque Psoriasis

Sernivo Spray (betamethasone dipropionate) is a topical corticosteroid indicated for the treatment of mild to moderate plaque psoriasis.

Briviact (brivaracetam)

Date of Approval: February 19, 2016
Company: UCB, Inc.
Treatment for: Epilepsy

Briviact (brivaracetam) is a selective, high-affinity synaptic vesicle protein 2A ligand and analog of levetiracetam indicated for the treatment of partial-onset seizures in patients with epilepsy.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.